Learning Objectives:

1.  List the Novel or Target-Specific Anticoagulants and discuss how they work. Compare and contrast to other classes of anticoagulants including the vitamin K antagonists (VKA) and the low-molecular weight heparins (LMWH). 

2.  Review the relevant clinical trials of the NOAC’s and their outcomes.  Be able to state the statistically significant findings.  

3.  Choose the “best” anticoagulant(s) for the patient. Discuss when and what type of monitoring is needed for patients.

4.  Be able to list the reversal agents for the NOAC’s and review how they work.

5.  Discuss the resources for periprocedural recommendations for NOAC’s. Become familiar with the ACCP (CHEST) Guidelines and Mayo Clinic Pharmacy guidelines. Mayo Clinic APPs for periprocedural anticoagulation will be reviewed.

Accreditation
Mayo Clinic College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Mayo Clinic College of Medicine designates this live activity for a maximum of  1.0 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Summary

As a provider accredited by ACCME, Mayo Clinic College of Medicine (Mayo School of CPD) must ensure balance, independence, objectivity and scientific rigor in its educational activities.  Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity.  Safeguards against commercial bias have been put in place.  Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation.  Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program who have disclosed…

No relevant financial relationship(s) with industry:

Planning Committee:
Dr. Jamie Newman – none                       

Dr. Neel Shah – none

Andy Herber PA-C – none

Kyle Satterblom, PA-C – none

Emily Sorensen, DNP, APRN, CNP – none

Abigail Meyers, PA-C – none

Liz Canan – none

Amy Van Hoof – none

Presenter - None

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:

None